Caux C, Vanbervliet B, Massacrier C, Durand I, Banchereau J
Laboratory for Immunological Research, Schering-Plough, Dardilly, France.
Blood. 1996 Mar 15;87(6):2376-85.
We have previously shown that tumor necrosis factor (TNF)alpha strongly potentiates the granulocyte-macrophage colony-stimulating factor (GM-CSF)/interleukin (IL)-3-dependent proliferation of CD34+ hematopoietic progenitor cells (HPC) through the recruitment of early progenitors with high proliferative potential. Furthermore, the combination of GM-CSF and TNFalpha allows the generation of large numbers of dendritic/Langerhans cells (D-Lc). Herein, we analyzed whether IL-3, when combined to TNFalpha would, as does GM-CSF, allow the generation of CD1a+ D-Lc. Accordingly, cultures of cord blood CD34+ HPC with IL-3 + TNFalpha yielded 20% to 60% CD14+ cells and 11% to 17% CD1a+ cells, while IL-3 alone did not generate significant numbers of CD1a+ cells. Although the percentage of CD1a+ cells detected in IL3 + TNFalpha was lower than that observed in GM-CSF + TNFalpha (42% to 78%), the strong growth induced by IL-3 + TNFalpha generated as many CD1a+ cells as did GM-CSF + TNFalpha. The CD14+ and CD1a+ cells generated with IL-3 + TNFalpha are similar to CD14+ and CD1a+ cells generated in GM-CSF alone and GM-CSF + TNFalpha, respectively. CD1a+ cells differed from CD14+ cells by (1) dendritic morphology, (2) higher expression of CD1a, CD1c, CD4, CD40, adhesion molecules (CD11c, CD54, CD58), major histocompatibility complex (MHC) class II molecules and CD28 ligands (CD80 and CD86), (3) lack of Fc receptor FcgammaRI (CD64) and complement receptor CR1 (CD35) expression, and (4) stronger induction of allogeneic T-cell proliferation. Thus, in combination with TNFalpha, IL-3 is as potent as GM-CSF for the generation of CD1a+ D-Lc from cord blood CD34+ HPC. The dendritic cell inducing ability of IL-3 may explain why mice with inactivated GM-CSF gene display dendritic cells.
我们之前已经表明,肿瘤坏死因子(TNF)α通过募集具有高增殖潜力的早期祖细胞,强烈增强粒细胞-巨噬细胞集落刺激因子(GM-CSF)/白细胞介素(IL)-3依赖的CD34+造血祖细胞(HPC)增殖。此外,GM-CSF和TNFα的组合可产生大量树突状/朗格汉斯细胞(D-Lc)。在此,我们分析了IL-3与TNFα联合时,是否会像GM-CSF一样,允许产生CD1a+ D-Lc。相应地,用IL-3 + TNFα培养脐血CD34+ HPC产生了20%至60%的CD14+细胞和11%至17%的CD1a+细胞,而单独使用IL-3并未产生大量CD1a+细胞。尽管在IL-3 + TNFα中检测到的CD1a+细胞百分比低于在GM-CSF + TNFα中观察到的百分比(42%至78%),但IL-3 + TNFα诱导的强烈生长产生的CD1a+细胞数量与GM-CSF + TNFα产生的一样多。用IL-3 + TNFα产生的CD14+和CD1a+细胞分别类似于单独使用GM-CSF和GM-CSF + TNFα产生的CD14+和CD1a+细胞。CD1a+细胞与CD14+细胞的不同之处在于:(1)树突状形态;(2)CD1a、CD1c、CD4、CD40、黏附分子(CD11c、CD54、CD58)、主要组织相容性复合体(MHC)II类分子和CD28配体(CD80和CD86)的表达较高;(3)缺乏Fc受体FcγRI(CD64)和补体受体CR1(CD35)的表达;(4)对异体T细胞增殖的诱导更强。因此,与TNFα联合时,IL-3在从脐血CD34+ HPC产生CD1a+ D-Lc方面与GM-CSF一样有效。IL-3的树突状细胞诱导能力可能解释了GM-CSF基因失活的小鼠为何会出现树突状细胞。